MCG ophthalmology, vision research benefit from Knights Templar support
“I think the best legacy any of us can hope for is to impact more Georgians."
With a PhD in Molecular Oncology and Immunology, you’ll be prepared for a career in basic and translational biomedical research, either in an academic environment or industry.
The program includes faculty members from clinical and basic science departments for an interdisciplinary approach to the understanding of disease processes.
By choosing to earn your doctorate in Molecular Oncology and Immunology from Augusta University, you’ll be joining a program that encourages you to design your own course of study.
Molecular Oncology and Immunology is for you if you consider yourself
Learning
like no
other.
Want to learn more about the Molecular Oncology and Immunology program at Augusta University?
Request InfoWhat You'll Study
Students in Augusta University’s Molecular Oncology and Immunology program are admitted via a common admissions process to the Biomedical Sciences doctoral program. After completing the first-year core coursework and laboratory rotations, students choose a dissertation research mentor and enter the Molecular Oncology and Immunology program.
The average time to completion of the degree is approximately five years of full-time, year-round study.
Curriculum | Admissions Criteria | Tuition and Fees | Application Deadlines
EXPLORE. EXCEL. EXPAND.
Augusta University's graduate programs are among the best in the nation – and the world – and our graduate students are our most valuable assets. To ensure that our students earn more than a degree, the Graduate School offers a range of opportunities so they can develop the leadership, communication and personal skills needed for a rewarding life and academic, research or professional career.
See what the Graduate School has to offer »
About the Graduate SchoolExperience-based Education
Augusta University is the primary healthcare-focused public research university in Georgia, and the program’s location on the Health Sciences Campus puts you at the heart of the university’s research enterprise.
Graduate Research Day offers you the chance to present your research and compete for awards and recognition.
The Georgia Cancer Center’s Grand Rounds series features talks on cancer-related topics intended expand interactions and initiate collaborations across departments and disciplines.
The program allows students to design their own program of study, individualizing learning opportunities and customizing research objectives.
Program alumni have found positions in highly respected universities and organizations, including Memorial Sloan Kettering Cancer Center and the Johns Hopkins University School of Medicine.
The program’s focus on tumor immunology gives graduates important skills valued by academic and clinical research, medicine and industry.
Molecular Oncology and Immunology faculty come from the basic sciences and clinical medicine to provide a truly interdisciplinary education.
Your Future
According to the U.S. Bureau of Labor Statistics, job growth for medical scientists is projected to rise much faster than average through 2031.
In 2021, the median pay for a medical scientist was $95,310 per year.
Profiles
Being an Augusta University Hurricane Irma Emergency Volunteer. It is always a great feeling to help people especially in tough situations like Hurricane Irma
Mohamed Hussein
I want to make a difference in science. Thus, I was looking for a translational research program. Molecular Medicine offered me the opportunity to impact patients’ life with my research.
Leidy Caraballo Galva
GPA: Overall GPA of 3.0 on a 4.0 scale at the Baccalaureate level calculated on all undergraduate work.
Degree Requirement: Minimum of a Bachelor’s degree or equivalent from an accredited college or university.
Transcripts: Official transcripts are required from all universities and colleges ever attended. Unofficial transcripts from US colleges and universities can be used in the admissions review process in lieu of official transcripts for this program.
Standardized Test Requirements: None are required for this program.
Letters of Recommendation: Recommendations from three individuals must be submitted through the application portal.
Resume: Applicants must submit a resume or curriculum vitae within the application portal.
Research Experience: Research experience is required for admission. Applicants will provide a personal statement that includes a summary and description of your research experience in the application portal.
International Students: Please review the verification process for international transcripts and the english proficiency requirement.
$4,801*
Estimated total
Full-time / In-State / Per Semester
$401
Tuition Per Hour
$675
Mandatory Fees
*Tuition & Fees listed here are for in-state students enrolling in the university for Fall 2024 semester.
Detailed Program Tuition InformationApplication fee waiver extended to Dec 15, 2023
Early submission of all application materials is strongly advised.
All required application materials and documents must be received in order for an application to be considered complete and before an admission decision can be made. The program does not accept applications after the published application deadline, however the program will continue to accept application materials up to 2 weeks after the application deadline.
Learning Like No Other
The program’s focus on the development of new approaches to disease treatment through the unique combination of basic science and translational medical research prepares graduates to make a difference in a variety of different environments.
Individualized programs of study allow you to tailor your research and focus on your career objectives.
The diverse, internationally recognized faculty provide the full spectrum of biomedical research training.
“I think the best legacy any of us can hope for is to impact more Georgians."
“We show, for the first time in this study, that many fibroblast cells are actually produced by these excessive endothelial cells. We must find a way to prevent this from happening,” said Yuqing Huo, MD.
This new database will help eliminate that problem and includes data from 307 human AH samples, comprehensive information on 1,683 proteins identified in the AH, as well as relevant clinical data for each analyzed sample.
The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast cancer (TNBC).